Therefore, despite the reported role of type B EPH receptors in the progression of colorectal cancer and the high frequency of EPHA3 mutations observed in early genome-wide mutatome analyses, our results indicate that modulation of EPHA3 signaling does not regulate the growth of intestinal cancer cells. Here, EPHA3 is linked to intestinal cancer.